Pfizer (PFE) Enters Settlement with Impax (IPXL) Over Detrol LA Application

August 23, 2012 4:39 PM EDT Send to a Friend
Pfizer Inc. (NYSE: PFE) is ticking higher in late trading Thursday following reports that it settled litigation with Impax Labs (Nasdaq: IPXL).

According to Bloomberg, Pfizer and Impax settled a patent lawsuit over an application for the generic form of Detrol LA.

Detrol LA is a bladder-control treatment.

Terms of the settlement weren't disclosed.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA, Litigation

Add Your Comment